Arkolith/Insider Trading/TCRX/Form 4

Lynx1 Capital Management LP

10% OwnerTScan Therapeutics, Inc. (TCRX) · full profile →Form 4 · filed May 21, 2025
Net Buying
Open-Market Buys
$3.1M
Open-Market Sells
$0
Net Open-Market Flow
$3.1M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2025Buy(P)1.2M$1.20$1.4M7.9M
May 19, 2025Buy(P)1.4M$1.20$1.7M6.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-25-002511) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML